To monitor AKT activation in a PTEN loss–driven prostate cancer model, the Akt-FRET biosensor mice were crossed with either the Pten−/+ model or the mutant PtenG129E/+ knock-in mouse line expressing a lipid phosphatase dead PTEN. This evidence concerns the gene AKT1 and prostate carcinoma.